Liminal BioSciences Competitors and Similar CompaniesClear all
Liminal BioSciences's competitors and similar companies include Biogen.
 Liminal BioSciences Liminal BioSciences is a biotechnology company developing small molecule compounds for respiratory, liver, and renal diseases. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | |
Founding Date | Founding Date 1994 | Founding Date 1978 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Laval, CA HQ Pampisford, GB | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 251 | Employees 7,605 |
Financial | ||
Revenue (est.) | Revenue (est.) $416k (FY, 2022) | Revenue (est.) $9.9b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) |
Gross profit | Gross profit $416k (FY, 2022) | Gross profit $7.5b (FY, 2025) |
Net income | Net income $1.2m (FY, 2022) | Net income $1.3b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company